Hypoglossal nerve stimulation for treatment of obstructive sleep apnea (OSA): a primer for oral and maxillofacial surgeons.
10.1186/s40902-017-0126-0
- Author:
Sung ok HONG
1
;
Yu Feng CHEN
;
Junho JUNG
;
Yong Dae KWON
;
Stanley Yung Chuan LIU
Author Information
1. Department of Dentistry (Oral and Maxillofacial Surgery), Catholic Kwandong University School of Medicine, International St. Mary's Hospital, Incheon, South Korea.
- Publication Type:Review
- Keywords:
Hypoglossal nerve;
Upper airway stimulation;
Obstructive sleep apnea;
Snoring;
Sleep endoscopy;
OSA surgical treatment;
Oral and maxillofacial surgeon
- MeSH:
Adult;
Cardiovascular Diseases;
Female;
Humans;
Hypoglossal Nerve*;
Insulin Resistance;
Korea;
Male;
Mortality;
Oral and Maxillofacial Surgeons*;
Prevalence;
Sleep Apnea, Obstructive*;
Snoring
- From:Maxillofacial Plastic and Reconstructive Surgery
2017;39(9):27-
- CountryRepublic of Korea
- Language:English
-
Abstract:
The prevalence of obstructive sleep apnea (OSA) is estimated to be 1–5% of the adult population world-wide, and in Korea, it is reported at 4.5% of men and 3.2% of women (Age 40 to 69 years old). Active treatment of OSA is associated with decrease in insulin resistance, cardiovascular disease, psychosocial problems, and mortality. Surgical treatment of OSA has evolved in the era of neuromodulation with the advent of hypoglossal nerve stimulation (HGNS). We share this review of HGNS with our maxillofacial surgical colleagues to expand the scope of surgical care for OSA.
